Company Filing History:
2 out of 15,488 
2 out of 42 
1 out of 5,452 
Years Active: 1998-2006
Title: Eva Y-hp Lee: Innovator in Cancer Treatment
Introduction
Eva Y-hp Lee is a prominent inventor based in San Antonio, Texas. She has made significant contributions to the field of cancer treatment through her innovative research and patented technologies. With a total of three patents, her work focuses on methods to control cell cycle progression and the development of novel proteins that bind to retinoblastoma.
Latest Patents
One of her latest patents is titled "Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells." This patent discloses methods for controlling cell cycle progression by introducing a composition that includes p56 protein or its gene into hyperproliferating cells. The p56 protein has been found to be soluble in low concentrations of glycerol, enhancing its pharmaceutical applications. Another significant patent involves "Nucleic acids encoding novel proteins which bind to retinoblastoma." This patent highlights the discovery of two nuclear proteins, p48 and p46, that bind to the retinoblastoma protein, Rb, and their potential role in modulating the suppressor function of Rb.
Career Highlights
Eva has worked with esteemed institutions such as the University of California and Canji Inc. Her research has been pivotal in advancing the understanding of retinoblastoma and developing therapeutic strategies for cancer treatment.
Collaborations
Throughout her career, Eva has collaborated with notable colleagues, including Wen-Hwa Lee and H. Michael Shepard. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Eva Y-hp Lee is a trailblazer in the field of cancer research, with her patents reflecting her commitment to advancing medical science. Her work continues to inspire future innovations in cancer treatment.